Company Filing History:
Years Active: 2020-2023
Title: Satoru Uchinuma: Innovator in Electroencephalography Technology
Introduction
Satoru Uchinuma is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of electroencephalography, particularly through his innovative patents. With a total of 2 patents, Uchinuma's work focuses on enhancing the technology used to measure brain activity.
Latest Patents
One of Uchinuma's latest patents is an electroencephalogram electrode. This electrode features a bottom portion designed to accommodate a connection member that supplies biological signals acquired from a subject through conductive gel to an external apparatus. It includes an annular wall that extends from the bottom portion, ensuring contact with the subject, and a series of barb members that hold the conductive gel within a designated space.
Another significant patent is his headwear for electroencephalography. This headwear is designed to securely hold multiple electroencephalogram electrodes in place. It consists of a first arm that attaches to the forehead or occiput of the subject, along with additional arms that connect to the lateral sides of the head. The design includes a stretchable support member and an adjusting mechanism to ensure a comfortable fit.
Career Highlights
Uchinuma is currently employed at Nihon Kohden Corporation, a leading company in the medical technology sector. His work there has allowed him to focus on developing advanced solutions for brain activity monitoring. His contributions have been instrumental in improving the accuracy and usability of electroencephalography devices.
Collaborations
Uchinuma has collaborated with several talented individuals in his field, including Kaoru Imajo and Shigehiro Nishiwaki. These collaborations have fostered innovation and have led to the development of cutting-edge technologies in electroencephalography.
Conclusion
Satoru Uchinuma's innovative work in electroencephalography has made a significant impact on the field. His patents reflect a commitment to advancing medical technology and improving the ways in which brain activity is monitored.